Skip to main content
Ottobock SE & Co. KGaA logo

Ottobock SE & Co. KGaA — Investor Relations & Filings

Ticker · OBCK ISIN · DE000BCK2223 LEI · 529900LR96WLQ75KCE70 F Manufacturing
Open in API
Filings indexed 41 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country DE Germany
Listing F OBCK

About Ottobock SE & Co. KGaA

https://www.ottobock.com

Ottobock is a medical technology company that develops products and services to restore or improve human mobility. The company's core business areas are prosthetics, orthotics, and exoskeletons. In prosthetics, it is known for advanced mechatronic solutions, including microprocessor-controlled knee joints. The orthotics division offers devices for support, correction, and pain relief for individuals with injuries or neurological conditions. Ottobock also develops industrial exoskeletons designed to create more ergonomic workplaces and reduce physical strain in sectors like manufacturing and logistics. The company supports users through a global network of patient care centers, providing customized fitting, treatment, and rehabilitation services to cover the full treatment cycle.

Recent filings

Filing Released Lang Actions
iconiq: Individualized liner from a 3D printer.
Regulatory Filings Classification · 78% confidence The document is a press release (EQS News) announcing a new product (3D-printed silicone liner) and contains no financial results, report attachments, management changes, dividends, or regulatory certifications. It is not an investor presentation or formal report, so it falls into the catch-all “Regulatory Filings” category for miscellaneous announcements. Therefore, it is classified as RNS.
2026-05-27 English
Ottobock SE & Co. KGaA categorically rejects misleading allegations in short-seller report
Regulatory Filings Classification · 78% confidence The document is a standalone corporate news release via EQS News in which Ottobock publicly rejects allegations made in a short‐seller report and outlines potential legal steps. It does not contain financial statements or results (so it is not an earnings release, interim report or annual report), nor does it announce dividends, board changes, proxy materials, or share issuances. It is a general regulatory/corporate announcement. Therefore it falls under the catch‐all Regulatory Filings category (RNS).
2026-05-20 English
Annual General Meeting approves dividend of EUR 0.97 per share
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a corporate news announcement summarizing outcomes from the Annual General Meeting: approval of a EUR 0.97 per share dividend, election of a supervisory board member, and reference to full voting results. It is not the AGM materials or full report itself but rather the official voting results and meeting outcomes. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-19 English
Ottobock SE & Co. KGaA: Ottobock acquires patient care business from Blatchford in Norway for approximately 110 million
M&A Activity Classification · 87% confidence The document is an ad-hoc regulatory announcement disclosing inside information pursuant to MAR regarding Ottobock’s acquisition of Blatchford Norway’s patient care business for €110 million. This is a merger & acquisition transaction announcement, i.e., M&A Activity. There is no detailed financial report or share issuance, nor is it merely a publication notice. Therefore it falls under M&A Activity (TAR).
2026-05-13 English
Ottobock will be presenting innovative prosthetics and orthotics solutions at OTWorld 2026.
Regulatory Filings Classification · 92% confidence The document is a corporate press release announcing product presentations at a trade fair (OTWorld 2026). It contains no financial figures, voting or regulatory details, nor is it an earnings release, report, or presentation for investors. It is a general corporate news announcement, which falls under the fallback category for miscellaneous regulatory announcements and press releases.
2026-05-11 English
Ottobock continues growth trajectory with significant margin increase
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Ottobock's quarterly financial results for the first quarter of 2026. It includes specific financial figures such as revenue, EBITDA, net income, segment performance, and guidance confirmation. The presence of comprehensive financial data and analysis for a quarter (January to March 2026) indicates this is a quarterly financial report. The document is over 11,000 characters, so it is not a brief announcement or a report publication notice. It is not an earnings release (which typically contains only key highlights), but a more comprehensive interim report with substantive financial data and segment analysis. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-06 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.